JCJoy Chowdhury

Joy Chowdhury

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Joy Chowdhury has a total of 13 co-authors. Here are the top co-authors by number of shared publications:

  • Aditya Sikand

    Robarts Research Institute Stroke Prevention and Atherosclerosis Research Centre

    2 shared publications
  • Azadeh Soltanifar

    Department of Community Medicine, School of Medicine, Mashhad University of Medical Sciences

    2 shared publications
  • Daniel G. Hackam

    Western University Department of Epidemiology and Biostatistics

    2 shared publications
  • J. David Spence

    Robarts Research Institute Stroke Prevention and Atherosclerosis Research Centre

    2 shared publications
  • Reza Azarpazhooh

    Robarts Research Institute Stroke Prevention and Atherosclerosis Research Centre

    2 shared publications
  • Areeb Hassan

    St Joseph’s Health Care London

    1 shared publication

Latest Publications

  • Open Access

    Landscape of Canadian Stroke Motor and Cognitive Rehabilitation Trials: Trends, Strengths and Future Directions

    by Robert W. Teasell, Mohammad R. Safaei-Qomi, Benjamin Peter Luebke, Joy Chowdhury, Brooke Gelinas, Areeb Hassan, Michelle Chow, Sean Dukelow, Sarvenaz Mehrabi

    This study aims to systematically identify and describe all randomized controlled trials (RCTs) evaluating post-stroke motor and cognitive rehabilitation conducted in Canada, within the broader context of global post-stroke rehabilitation research. The present secondary descriptive/bibliometric analysis used data derived from five integrated systematic reviews conducted by the same research group, from inception to 2024. A subset of data was examined in Canadian trials, including number of RCTs, sample size, participant sex, time post-stroke, methodological quality, intervention types and outcome measures. In total, 106 out of 3602 global RCTs were conducted in Canada. Canadian RCT relative contribution to global research has slowed down over time. Sample size was significantly smaller in the chronic post-stroke phase compared to acute and subacute phases in both Canadian ( p = 0.013) and global trials ( p < 0.001). Compared to global trials, Canadian RCTs had comparable sample size ( p = 0.72) and methodological quality ( p = 0.94) but were more likely to be conducted in the chronic phase ( p = 0.001), evaluate exercise-based and rehabilitation-oriented interventions and assess activity and participation outcome measures. Chronic trials were more likely to be led by academic therapists ( p = 0.031), while the acute and subacute trials were more likely to be led by academic physicians ( p = 0.003). Canadian RCTs have made important contributions to stroke rehabilitation research. However, expanding research into earlier recovery phases, integrating technology-driven interventions and incorporating outcome measures across all three International Classification of Functioning, Disability and Health domains will be important to strengthening Canada’s impact and advancing stroke rehabilitation evidence.

  • Association between ABO Blood Groups, Carotid Stenosis and Atherosclerotic Plaque Burden: A Retrospective Cohort Study

    by Joy Chowdhury, Aditya Sikand, J. David Spence, Azadeh Soltanifar, Daniel G. Hackam, Reza Azarpazhooh

    Background: Some studies report that certain blood groups are associated with vascular disease. However, only a few studies have assessed the association between atherosclerosis and ABO blood groups. We investigated whether ABO blood groups are associated with carotid atherosclerosis. Methods: A retrospective cohort study of 3855 patients from 1985 to 2021 at the Stroke Prevention and Atherosclerosis Research Center (SPARC). The database included patients with a history of vascular disease and those referred to SPARC for primary prevention. Carotid plaque burden was measured as total plaque area; percent stenosis was calculated from peak systolic velocity. Total plaque area and stenosis are compared in blood groups, using unadjusted comparisons. Quantile regression analyses were performed adjusting for risk factors including age, sex, blood pressure and smoking status. The association between carotid stenosis and blood groups was analyzed using logistic regression models. Subgroup analysis was stratified by presence or absence of vascular disease at baseline and the burden of atherosclerosis. Results: In quantile regression analysis, we found no significant associations between total plaque area and ABO blood groups. Carotid stenosis as a categorical and binary variable (defined as cases with stenosis ≥50% vs. < 50%) and total plaque area as a binary variable (TPA ≥ 1.19 cm 2 vs. 2 ) had no association with ABO blood groups. In patients with cardiovascular disease (CVD), there was no association between blood groups and total plaque area. Conclusion: Blood groups are not associated with carotid atherosclerosis. Prevention efforts should focus on controlling risk factors and living a healthy lifestyle.